Neurodiagnostics Market Will Be Worth $18.3 Billion By 2024: Grand View Research, Inc.
The global neurodiagnostics market was valued at 13.6 billion
in 2015 and is expected to reach a value of USD 18.3 billion by 2024, according
to a new report by Grand View Research, Inc. Key factors driving the market
growth include increasing prevalence of neurological diseases due to
demographic changes and growing awareness of their management. In addition,
consistent technological modifications coupled with increased preference for
novel diagnostic technologies will further fuel the market. The economic burden
of neurological diseases is extremely high on society and governments with
around 1 billion people suffering globally.
Among all the neuroimaging techniques, computed tomography
has the largest market share followed by Magnetic Resonance Imaging (MRI).
Computed Tomography (CT) uses ionized radiations for the purpose of creating
images, whereas MRI uses radio waves in a magnetic field. Neuroimaging
techniques are used to detect brain injuries, developmental malformations in
the brain area, vascular irregularities that may lead to stroke, epilepsy, etc.
Biomarkers are an important part of in vitro diagnostics for
neurological disorders as their development is targeted at the early disease
diagnosis with information about nervous system. Although biomarkers are not
commercially available in the market, their use is confined to clinical
research settings. For instance, ELISA tests for Tau protein are available in
clinical studies of Alzheimer’s disease. In addition, neuroinformatics is a
field that studies neuroscience and information technology. This integration
allows the storage of neurological data in the form databases. The
neuroinformatics market is expected to grow at second highest growth rate
during the forecast period.
Browse full research report on Global Neurodiagnostics Market:
Further Key Findings From the Study Suggest:
- Increased
life expectancy has resulted in increased geriatric population across the
globe. The prevalence of aging-related neurological diseases such as
Alzheimer’s disease and Parkinson’s disease is on the rise. The diagnosis
of these diseases includes neuroimaging, in vitro diagnosis, and
neuroinformatics.
- CT and
MRI are the most commonly used imaging techniques across the globe, which
are mainly used to detect brain abnormalities.
- Neurological
biomarkers are extremely promising as they provide a direction to the
diagnostic studies. Although currently no commercial biomarker is
available in the market, an extensive clinical research is happening to
find out the perfect combinations of the biomarkers.
- North
America held the major market share of around 36% in the year 2015 and
will retain its top position during the forecast period. On the other
hand, Asia Pacific will exhibit highest CAGR of 4% over the forecast
period.
Browse more reports of this category by Grand View
Research:
http://www.grandviewresearch.com/industry/medical-devices
http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the Neurodiagnostics
market by Technology, and region:
Technology Outlook (Market revenue in USD Million, 2013
- 2024)
- Neuroimaging
Technologies
- Computed
Tomography (CT)
- Magnetic
Resonance Imaging (MRI)
- Nuclear
Medicine Imaging (PET, SPECT)
- Near
Infrared Spectroscopic Imaging (NIRS)
- Electroencephalography
(EEG)
- Magnetoencephalography
(MEG)
- Voxel-based
Morphometry (VBM)
- In
Vitro Diagnostics
- Neuroinformatics
Regional Outlook (Market Revenue in USD Million,
2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-neurodiagnostics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment